Cytophage Technologies Inc. announced that it has signed a letter of intent for private placement of equity securities for gross proceeds of a minimum of $3,000,000 and a maximum of $5,000,000 on June 1, 2023. The transaction included participation from new investor, Cuspis Capital III Ltd.